Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019.
Saved in:
| Title: | Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019. |
|---|---|
| Authors: | Zhang J; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Lu Y; Department of Pharmacy, The Third People's Hospital of Chengdu, Chengdu, China., Kwong JS; Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan., Li X; Department of Pharmacy, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China., Zheng W; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.; Clinical Research Center and Center of Allogeneic Stem Cell Transplantation(CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden., He R; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.; Clinical Research Center and Center of Allogeneic Stem Cell Transplantation(CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2020 Aug 27; Vol. 11, pp. 1330. Date of Electronic Publication: 2020 Aug 27 (Print Publication: 2020). |
| Publication Type: | Systematic Review; Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32973535 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.<br /><searchLink fieldCode="AU" term="%22Lu+Y%22">Lu Y</searchLink>; Department of Pharmacy, The Third People's Hospital of Chengdu, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Kwong+JS%22">Kwong JS</searchLink>; Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Pharmacy, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Zheng+W%22">Zheng W</searchLink>; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.; Clinical Research Center and Center of Allogeneic Stem Cell Transplantation(CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22He+R%22">He R</searchLink>; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.; Clinical Research Center and Center of Allogeneic Stem Cell Transplantation(CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2020 Aug 27; Vol. 11, pp. 1330. <i>Date of Electronic Publication: </i>2020 Aug 27 (<i>Print Publication: </i>2020). – Name: TypePub Label: Publication Type Group: TypPub Data: Systematic Review; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32973535 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2020.01330 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1330 Titles: – TitleFull: Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Lu Y – PersonEntity: Name: NameFull: Kwong JS – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Zheng W – PersonEntity: Name: NameFull: He R IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 08 Text: 2020 Aug 27 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 11 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |